Trial Profile
A Phase IIa Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Multiple Doses of Inhaled RNS60 and Budesonide on the Late Phase Asthmatic Response to Allergen Challenge in Patients With Mild Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs RNS 60 (Primary) ; Budesonide
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Revalesio
- 04 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2015 According to ClinicalTrials.gov record, this trial has been amended to no longer be a cross-over trial; it will be parallel (RNS60/placebo) 1 period study and no longer involves the administration of budesonide.
- 07 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.